Activ Surgical
Private Company
Total funding raised: $86.2M
Overview
Activ Surgical is pioneering the field of intraoperative surgical intelligence with a focus on augmented reality, artificial intelligence, and machine learning to improve surgical safety and outcomes. The company's first commercial product is the ActivSight™ Intelligent Light, an enhanced visualization module compatible with existing minimally invasive surgery (MIS) systems, which received CE Mark approval. Backed by a broader platform called ActivEdge™, Activ Surgical aims to transform surgical standards by making advanced, data-driven insights accessible to all surgeons, thereby addressing the significant global burden of preventable surgical errors.
Technology Platform
The ActivEdge™ Platform integrates augmented reality (AR), artificial intelligence (AI), machine learning (ML), and sensing technologies to provide real-time intraoperative visual insights and data to surgeons, aiming to map the surgical field and reveal critical physiological structures not visible to the naked eye.
Funding History
6Opportunities
Risk Factors
Competitive Landscape
Activ Surgical competes in the surgical visualization and digital surgery space against major medtech players like Stryker (with its 1688 AIM platform), Karl Storz, Olympus, and Medtronic, as well as robotic surgery leader Intuitive Surgical, which integrates advanced imaging. Its differentiation lies in its platform-agnostic, AI-driven approach and its initial focus on dye-free perfusion imaging.